<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9119">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02988219</url>
  </required_header>
  <id_info>
    <org_study_id>U/1/2010</org_study_id>
    <nct_id>NCT02988219</nct_id>
  </id_info>
  <brief_title>Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method</brief_title>
  <official_title>Evaluation of Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the incidence of cardiac arrhythmias during the perioperative period in
      patients undergoing open kidney cancer surgery in the lateral position. All the participants
      will be randomly allocated to receive general (Group G) or combined epidural/general
      anaesthesia (Group G/E). The anaesthetic technique is standardized. The Holter monitor will
      be applied at the evening before the surgery, tracing continuously for a period of 24 hours
      (7PM-7PM)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac arrhythmias are a common complication during and after cardio-thoracic surgery. They
      are also a major source of morbidity and mortality. After general surgery, they usually do
      not require clinically significant management but the literature on this topic is obsolete.
      There is no literature data about their incidence during kidney surgery in the lateral
      position when the bed is scissored so the legs and head are low. The aim of this study was
      to define what types of arrhythmias are the most common during kidney cancer surgery, their
      incidence and whether combining general with epidural anesthesia prevents them.

      An approval from the Medical University of Warsaw Bioethical Committee has been obtained.
      Patients need to give written informed consent to participate in the study.

      It is anticipated that 50 patients with open kidney cancer surgery performed in the lateral
      position, under general or combined anesthesia will be enrolled.

      A Holter ECG monitor (3-chanel, leads CM5) will be applied at the evening before the
      surgery, tracing continuously for a period of 24 hours (7PM-7PM).

      Patients will be randomly allocated (random permuted blocks within strata) to receive
      general or combined epidural/general anesthesia. The anesthetic technique is standardized.
      All the data registered by the Holter ECG monitor will be analyzed and compared with the
      nursery and anesthesia records.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of perioperative cardiac arrhythmias evaluated by a continuous ECG Holter monitoring in the perioperative period</measure>
    <time_frame>60 months</time_frame>
    <description>The investigator evaluates the incidence of cardiac arrhythmias, the type of arrhythmias and whether additional interventions were needed to treat them</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The prevention of cardiac arrhythmias occurence by epidural anesthesia added to general anesthesia evaluated by a number and type of arrhythmias observed</measure>
    <time_frame>60 months</time_frame>
    <description>The investigator evaluates the incidence of cardiac arrhythmias depending on anesthesia method by observing the number and type of arrhythmias and whether additional interventions were needed to treat them</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Arrhythmia, Cardiac</condition>
  <condition>Kidney Cancer</condition>
  <condition>Surgery</condition>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>General anesthesia (G)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Holter ECG monitor General anesthesia Open kidney cancer surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined general/epidural (G/E)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Holter ECG monitor Epidural anesthesia General anesthesia Open kidney cancer surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural anesthesia</intervention_name>
    <description>Local anesthetic</description>
    <arm_group_label>Combined general/epidural (G/E)</arm_group_label>
    <other_name>Marcaine</other_name>
    <other_name>Sensorcaine</other_name>
    <other_name>Astra Zeneca</other_name>
    <other_name>Adrenaline</other_name>
    <other_name>Bupivacaine-epinephrine</other_name>
    <other_name>Fentanyl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Holter ECG monitor</intervention_name>
    <description>3-chanel, CM5 leads</description>
    <arm_group_label>General anesthesia (G)</arm_group_label>
    <arm_group_label>Combined general/epidural (G/E)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open kidney cancer surgery</intervention_name>
    <description>Lateral position</description>
    <arm_group_label>General anesthesia (G)</arm_group_label>
    <arm_group_label>Combined general/epidural (G/E)</arm_group_label>
    <other_name>nephron sparing surgery (NSS)</other_name>
    <other_name>Radical nephrectomy</other_name>
    <other_name>Extraperitoneal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General anesthesia</intervention_name>
    <arm_group_label>General anesthesia (G)</arm_group_label>
    <arm_group_label>Combined general/epidural (G/E)</arm_group_label>
    <other_name>Intubation</other_name>
    <other_name>Fentanyl</other_name>
    <other_name>Narcosis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Open renal cell carcinoma surgery, lateral position

          -  American Society of Anesthesiologists (ASA) physical grade I-III

          -  No history of cardiac arrhythmias

          -  Informed consent

        Exclusion Criteria:

          -  Pregnancy and breast feeding

          -  Contraindications for epidural anesthesia

          -  Laparoscopic or robotic surgery

          -  Suspected difficult intubation (ex. fibroscopic)

          -  Chest deformations

          -  Prior cardiac/thoracic surgery

          -  Cardiac insufficiency

          -  abnormal ECG before the surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karolina Dobronska, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>I Department of Anaesthesiology and Intensive Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karolina Dobronska, MD</last_name>
    <phone>48 501 323 534</phone>
    <email>karolinapladzyk@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lidia I Jureczko, PhD MD</last_name>
    <phone>48 501 054 419</phone>
    <email>jureczko@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>I Department of Anaesthesiology and Intensive Care, Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <zip>02-005</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karolina Dobronska, MD</last_name>
      <phone>+48 22 501 17 27</phone>
      <email>karolinapladzyk@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Lidia I Jureczko, PhD MD</last_name>
      <phone>+48 22 501 17 27</phone>
      <email>jureczko@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Karolina Dobronska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lidia I Jureczko, PhD MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 8, 2016</lastchanged_date>
  <firstreceived_date>December 6, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Warsaw</investigator_affiliation>
    <investigator_full_name>Karolina Dobro≈Ñska</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>cardiac arrhythmia</keyword>
  <keyword>epidural anesthesia</keyword>
  <keyword>combined anesthesia</keyword>
  <keyword>general anesthesia</keyword>
  <keyword>NSS</keyword>
  <keyword>radical nephrectomy</keyword>
  <keyword>extraperitoneal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
